Pfizer to buy Anacor Pharma in $5.2b deal

Pfizer to buy Anacor Pharma in $5.2b deal

The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly

Pfizer Inc will buy Anacor Pharmaceuticals Inc in a deal valued at $5.2 billion, net of cash, to gain access to Anacor’s experimental gel for treating eczema.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter